Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.583
-0.026 (-4.33%)
At close: Feb 21, 2025, 4:00 PM
0.580
-0.003 (-0.51%)
After-hours: Feb 21, 2025, 7:38 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $24.23 million as of February 21, 2025. Its market cap has decreased by -66.47% in one year.
Market Cap
24.23M
Enterprise Value
2.80M
1-Year Change
-66.47%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $24.23M, a decrease of -90.55%. That is a compound annual growth rate of -50.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 24.23M | -16.84% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |